Treosulfan (Treo)

DRUG2 trials

Sponsors

Technische Universität Dresden, Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Conditions

AML - Acute Myeloid LeukemiaHSCTMDS (Myelodysplastic Syndrome)Nijmegen Breakage SyndromeTreosulfan Based Conditioning

Phase 2

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

RecruitingNCT07025824

Technische Universität DresdenAML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome)

Start: 2026-01-21End: 2029-09-01Target: 220Updated: 2026-09-02

Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

Not yet recruitingNCT07316595

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyHSCT, Nijmegen Breakage Syndrome, Treosulfan Based Conditioning

Start: 2025-12-30End: 2030-12-31Target: 24Updated: 2026-01-05